Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 31.92% is in line with its 5-year average of 30.11%, near the high end of its 5-year range (18.80%–35.78%).
0.81% below its 12-month average of 32.18%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 31.23%.
OPERATING MARGIN
31.92%
OPERATING MARGIN AVG TTM
32.18%
OPERATING MARGIN AVG 3Y
30.75%
OPERATING MARGIN AVG 5Y
30.11%
OPERATING MARGIN AVG 10Y
24.40%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.81%
CURRENT VS 3Y AVG
+3.82%
CURRENT VS 5Y AVG
+6.00%
CURRENT VS 10Y AVG
+30.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
IRadimed Corporation
Market Cap
$1.08B
Operating Margin
31.92%
TTM Avg
32.18%
3Y Avg
30.75%
5Y Avg
30.11%
Market Cap
$1.09B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.09B
Operating Margin
-36.08%
TTM Avg
-28.70%
3Y Avg
-24.53%
5Y Avg
-15.51%
Market Cap
$1.10B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Operating Margin
-19.19%
TTM Avg
-19.19%
3Y Avg
-4.83%
5Y Avg
3.07%
Market Cap
$1.11B
Operating Margin
-4.13%
TTM Avg
-9.12%
3Y Avg
-15.26%
5Y Avg
-9.90%
Market Cap
$1.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.05B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$1.13B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRadimed Corporation (IRMD) | $1.08B | 31.92% | 32.18% | 30.75% | 30.11% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| OPKO Health, Inc. (OPK)vs › | $1.09B | -36.08% | -28.70% | -24.53% | -15.51% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| STAAR Surgical Company (STAA)vs › | $1.10B | -19.19% | -19.19% | -4.83% | 3.07% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -4.13% | -9.12% | -15.26% | -9.90% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -6.98% | -25.06% | -156.73% | -114.38% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 14.18% | 9.30% | 5.28% | 4.02% |
Gross Margin
75.9%
Operating Margin
31.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 31.23% |
| 2026-03-31 | 32.93% |
| 2025-12-31 | 31.26% |
| 2025-09-30 | 32.23% |
| 2025-06-30 | 33.26% |
| 2025-03-31 | 27.84% |
| 2024-12-31 | 29.91% |
| 2024-09-30 | 31.59% |
| 2024-06-30 | 31.39% |
| 2024-03-31 | 26.98% |
| 2023-12-31 | 29.57% |
| 2023-09-30 | 35.78% |
| 2023-06-30 | 30.77% |
| 2023-03-31 | 25.89% |
| 2022-12-31 | 28.62% |
| 2022-09-30 | 30.82% |
| 2022-06-30 | 32.75% |
| 2022-03-31 | 24.98% |
| 2021-12-31 | 26.19% |
| 2021-09-30 | 28.30% |
| 2021-06-30 | 18.80% |
| 2021-03-31 | 19.27% |
| 2020-12-31 | 7.62% |
| 2020-09-30 | 10.19% |
| 2020-06-30 | -43.11% |
| 2020-03-31 | 8.50% |
| 2019-12-31 | 20.56% |
| 2019-09-30 | 25.28% |
| 2019-06-30 | 25.75% |
| 2019-03-31 | 17.94% |
| 2018-12-31 | 21.50% |
| 2018-09-30 | 19.02% |
| 2018-06-30 | 22.71% |
| 2018-03-31 | 15.30% |
| 2017-12-31 | 14.91% |
| 2017-09-30 | 3.45% |
| 2017-06-30 | 5.93% |
| 2017-03-31 | -4.62% |
| 2016-12-31 | 25.13% |
| 2016-09-30 | 33.80% |
| 2016-06-30 | 33.84% |
| 2016-03-31 | 38.84% |
| 2015-12-31 | 38.09% |
| 2015-09-30 | 39.09% |
| 2015-06-30 | 35.40% |
| 2015-03-31 | 32.39% |
| 2014-12-31 | 6.29% |
| 2014-09-30 | 10.66% |
| 2014-06-30 | 34.26% |
| 2014-03-31 | 23.17% |
| 2013-12-31 | 20.91% |
| 2013-09-30 | 14.35% |
| 2013-06-30 | 28.10% |
| 2013-03-31 | 35.34% |
